Clinical Trials
All Clinical Trials - Page 71 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT00242541Phase 4Terminated
Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas
Octreotide
- NCT00627796Phase 4Completed
Lanreotide Autogel-120 mg as First-Line Treatment of Acromegaly
Lanreotide
- NCT00226122Phase 4Completed
The Effect of Indomethacin in Monosymptomatic Enuresis Nocturnal
Desmopressin
- NCT01620463Phase 1Completed
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Healthy Japanese Volunteers
Liraglutide
- NCT00543218Phase 3Completed
PTH Comparison in Post Menopausal Women
Teriparatide
- NCT00128232Phase 3Completed
Safety and Efficacy of Octreotide Long Acting Release (LAR) in Treatment Naïve Acromegalic Patients
Octreotide
- NCT00050635Phase 4Completed
STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
Octreotide
- NCT00429494Phase 2Completed
GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients
Gonadorelin
- NCT00111540Phase 3Completed
Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes
Exenatide
- NCT00107107Phase 3Completed
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
Pramlintide
- NCT00051558Phase 3Completed
Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis
Teriparatide
- NCT00225979Phase 3Completed
Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly
Octreotide
- NCT00226967N/ACompleted
Stress, Diurnal Cortisol, and Breast Cancer Survival
Octreotide
- NCT02749825Phase 4Terminated
Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer
Gonadorelin
- NCT00034047Phase 1/Phase 2Completed
Endometriosis : Traditional Medicine vs Hormone Therapy
Gonadorelin
- NCT01789957Phase 3Completed
Extension Study for 2993-112
Exenatide
- NCT00145405Phase 4Completed
Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction
Octreotide
- NCT01511172Phase 2Completed
Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes
Liraglutide
- NCT00044694Phase 2Completed
Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus
Exenatide
- NCT00044668Phase 3Completed
Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination
Exenatide
- NCT00044707Phase 2Completed
Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide
Pramlintide
- NCT00191425Phase 4Completed
2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis
Teriparatide
- NCT00911443Phase 2Completed
Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma
Thymosin-Alpha-1
- NCT01510054N/AWithdrawn
Endometrial Luteal Phase Characteristics and Luteal Phase Support in Controlled Ovarian Stimulation Protocols With GnRH Antagonists:Focusing on MicroRNA
Gonadorelin
- NCT00042601Phase 2Completed
Evaluation of the Effect of Pramlintide on Satiety and Food Intake
Pramlintide
- NCT00206258Phase 3Completed
The Role of Amylin and Glucagon in T1DM
Pramlintide
- NCT00171886Phase 4Completed
Octreotide Efficacy and Safety in First-line Acromegalic Patients
Octreotide
- NCT00042471Phase 2Completed
Evaluation of the Bioavailability of Pramlintide
Pramlintide
- NCT00241020Phase 3Completed
Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma
Octreotide
- NCT00039962Phase 3Completed
Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin
Thymosin-Alpha-1
- NCT00035984Phase 3Completed
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
Exenatide
- NCT00040027Phase 3Completed
Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin
Thymosin-Alpha-1
- NCT00042458Phase 3Completed
Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control
Pramlintide
- NCT00033605Phase 3Completed
Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
Octreotide
- NCT00245479Phase 4Completed
A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis
Desmopressin
- NCT00039013Phase 3Completed
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin
Exenatide
- NCT00223691Phase 1Completed
Treatment of Orthostatic Hypotension in Autonomic Failure
Octreotide
- NCT01264497Phase 2Completed
Safety Study of TH9507 in Subjects With Stable, Type 2 Diabetes
Tesamorelin
- NCT00039026Phase 3Completed
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea
Exenatide
- NCT00953394Phase 2Completed
5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine Tumors
Octreotide
- NCT00386022Phase 2/Phase 3Unknown
The Effects of Aging and Estrogen on the Pituitary
Gonadorelin
- NCT00094146Phase 2Completed
Sandostatin LAR® Depot in Patients With Primary Insulin Hypersecretion (PIH) and at Least Moderate Obesity
Octreotide
- NCT00049023Phase 1Completed
Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
Octreotide
- NCT00235937Phase 2Completed
Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex
Gonadorelin
- NCT00026377Phase 1Completed
SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Gonadorelin
- NCT00220350Phase 2/Phase 3Unknown
Lupron Sex Offender Therapy
Gonadorelin
- NCT01511159Phase 1Completed
Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers
Liraglutide
- NCT00035256Phase 4Completed
Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis
Teriparatide
- NCT00171873Phase 3Completed
Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut
Octreotide
- NCT00586898Phase 2Completed
Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle
Gonadorelin